| 9090689 |
Use of TNFα inhibitor for treatment of psoriasis |
Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey +7 more |
2015-07-28 |
$136,617,000 |
| 9085620 |
Use of TNFα inhibitor for treatment of psoriatic arthritis |
Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey +7 more |
2015-07-21 |
$144,258,000 |
| 9035030 |
Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same |
Jochen G. Salfeld, Michael Roguska, Michael Paskind, Daniel Edward Tracey, Michael White +16 more |
2015-05-19 |
$90,169,000 |
| 8906373 |
Use of TNF-alpha inhibitor for treatment of psoriasis |
Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey +7 more |
2014-12-09 |
$81,481,000 |
| 8865174 |
Methods of treatment using human antibodies that bind IL-12 |
Jochen G. Salfeld, Michael Roguska, Michael Paskind, Daniel Edward Tracey, Michael White +16 more |
2014-10-21 |
$160,090,000 |
| 8765918 |
Human antibodies that bind human interleukin-12 |
Jochen G. Salfeld, Michael Roguska, Michael Paskind, Daniel Edward Tracey, Michael White +16 more |
2014-07-01 |
$23,443,000 |
| 7883704 |
Methods for inhibiting the activity of the P40 subunit of human IL-12 |
Jochen G. Salfeld, Michael Roguska, Michael Paskind, Daniel Edward Tracey, Michael White +16 more |
2011-02-08 |
$25,002,000 |
| 7504485 |
Human antibodies that bind human IL-12 |
Jochen G. Salfeld, Michael Roguska, Michael Paskind, Daniel Edward Tracey, Michael White +16 more |
2009-03-17 |
$109,246,000 |
| 6914128 |
Human antibodies that bind human IL-12 and methods for producing |
Jochen G. Salfeld, Michael Roguska, Michael Paskind, Daniel Edward Tracey, Michael White +16 more |
2005-07-05 |
$90,946,000 |
| 6100445 |
Transgenic knockout mouse having functionally disrupted interleukin-1.beta. converting enzyme gene |
Tara Seshadri, Ping Li, Hamish Allen, Michael Paskind |
2000-08-08 |
$663,000 |
| 6054487 |
Methods and compositions for modulating responsiveness to corticosteroids |
Les Sekut, Adam Carter, Tariq Ghayur, Daniel Edward Tracey |
2000-04-25 |
|
| 6015790 |
Methods and compositions for treating rheumatoid arthritis |
Teresa Barlozzari, Andreas Haupt |
2000-01-18 |
|
| 5932549 |
N-substituted glutamic acid derivatives with interleukin-1.beta. converting enzyme inhibitory activity |
Hamish Allen, Kenneth Dale Brady, John C. Hodges, Catherine R. Kostlan, Robert V. Talanian |
1999-08-03 |
$149,922,000 |
| 5744451 |
N-substituted glutamic acid derivatives with interleukin-1 .beta. converting enzyme inhibitory activity |
Hamish Allen, Kenneth Dale Brady, John C. Hodges, Catherine R. Kostlan, Robert V. Talanian |
1998-04-28 |
$436,683,000 |
